Our Research and Discovery Team
At the core of the biopharmaceutical industry are the scientists transforming their formalized curiosity into actional therapeutic advancements. The dedicated individuals working in discovery, research and development are committed to scientific excellence in all different areas of the industry from computational biology to biophysics. If your company is eager to find a scientist who will turn ideas into innovation, then reach out to our R&D team today.
Areas of Focus:
- Discovery Biology & Chemistry
- Target Identification & Validation
- HTS and Platform Development
- Pharmacology & Toxicology
- Translational Biology
- Bioanalytical
- DMPK
- Computational Biology
- Bioinformatics
- Program Management
Sample of Completed R&D Searches
Permanent
Vice President, CNS Gene Editing, Cambridge, MA: Mid-sized biotech developing genomic medicines
Vice President of DMPK, San Francisco, CA: Mid-sized biotech evolving medicines for oncology
Executive Director, Immunology, Framingham, MA: Startup biotech advancing novel therapies for oncology and autoimmune diseases
Senior Director, Translational Sciences, Cambridge, MA: Small biotech advancing programmable therapeutics for multiple diseases
Senior Director, Toxicology, Waltham, MA: Mid-sized clinical-stage biotech expanding therapies for antibody technologies
Senior Director, Boston, MA: Large biotech advancing synthetic biology for various therapeutic areas
Director, Protein Sciences, Cambridge, MA: Mid-sized biotech developing genomic medicines
Director, IO Development, Boston, MA: Small biotech creating immune cell therapies for treating patients with cancer and immune disorders
Director, Oncology, Cambridge, MA: Small biotech developing therapies for the treatment of cancer and other diseases
Director, Biology, Watertown, MA: Small biopharmaceutical company focused on developing therapies for hematologic disorders
Director, Immuno-Oncology, Waltham, MA: Mid-sized clinical-stage biotech expanding therapies for antibody technologies
Director, Research, London/Greater Boston, MA: Small clinical-stage biotech expanding psychedelics for medicine
Director, Immunology, Cambridge, MA: Small biotech developing therapies for the treatment of cancer and other diseases
Director, RNA & Protein Sciences, Boston, MA: Small biotech progressing ncRNA for immunology and oncology
Director, Preclinical Safety, Cambridge, MA: Small biotech improving novel approaches for genetic disorders
Director, Innovation & Exploratory Research, Cambridge, MA: Small, clinical stage company developing immunotherapy treatments utilizing T cell therapies for cancer patients
Director of Bioinformatics and Head of Data Science, Cambridge, MA: Startup biotech expanding RNA for oncology
Director of In Vitro Pharmacology, Boston, MA: Mid-sized biotech growing AI drug discovery for oncology and neurodegeneration
Associate Director, Protein Engineering, Cambridge, MA: Mid-sized biotech developing genomic medicines
Associate Director, Immunology (Macrophage Cell Therapy), Cambridge, MA: Mid-sized biotech engineering cell therapies for multiple therapeutics areas
Associate Director, Watertown, MA: Small biopharmaceutical company focused on developing therapies for hematologic disorders
Associate Director, In Vivo Pharmacology, Greater Boston, MA: Mid-sized biotech company developing cell and gene therapies
Associate Director, Program Management, Watertown, MA: Small, Clinical-stage biopharma company developing RNA-modulating drugs to treat rare and ultra-rare diseases
Associate Director, Toxicology, Greater Boston, MA: Mid-sized clinical stage biopharma developing novel biologic treatments for rare diseases
Associate Director, Cell Therapy, Cambridge, MA: Mid-sized biotech pioneering cell therapies for intractable diseases
Vice President of DMPK, San Francisco, CA: Mid-sized biotech evolving medicines for oncology
Executive Director, Immunology, Framingham, MA: Startup biotech advancing novel therapies for oncology and autoimmune diseases
Senior Director, Translational Sciences, Cambridge, MA: Small biotech advancing programmable therapeutics for multiple diseases
Senior Director, Toxicology, Waltham, MA: Mid-sized clinical-stage biotech expanding therapies for antibody technologies
Senior Director, Boston, MA: Large biotech advancing synthetic biology for various therapeutic areas
Director, Protein Sciences, Cambridge, MA: Mid-sized biotech developing genomic medicines
Director, IO Development, Boston, MA: Small biotech creating immune cell therapies for treating patients with cancer and immune disorders
Director, Oncology, Cambridge, MA: Small biotech developing therapies for the treatment of cancer and other diseases
Director, Biology, Watertown, MA: Small biopharmaceutical company focused on developing therapies for hematologic disorders
Director, Immuno-Oncology, Waltham, MA: Mid-sized clinical-stage biotech expanding therapies for antibody technologies
Director, Research, London/Greater Boston, MA: Small clinical-stage biotech expanding psychedelics for medicine
Director, Immunology, Cambridge, MA: Small biotech developing therapies for the treatment of cancer and other diseases
Director, RNA & Protein Sciences, Boston, MA: Small biotech progressing ncRNA for immunology and oncology
Director, Preclinical Safety, Cambridge, MA: Small biotech improving novel approaches for genetic disorders
Director, Innovation & Exploratory Research, Cambridge, MA: Small, clinical stage company developing immunotherapy treatments utilizing T cell therapies for cancer patients
Director of Bioinformatics and Head of Data Science, Cambridge, MA: Startup biotech expanding RNA for oncology
Director of In Vitro Pharmacology, Boston, MA: Mid-sized biotech growing AI drug discovery for oncology and neurodegeneration
Associate Director, Protein Engineering, Cambridge, MA: Mid-sized biotech developing genomic medicines
Associate Director, Immunology (Macrophage Cell Therapy), Cambridge, MA: Mid-sized biotech engineering cell therapies for multiple therapeutics areas
Associate Director, Watertown, MA: Small biopharmaceutical company focused on developing therapies for hematologic disorders
Associate Director, In Vivo Pharmacology, Greater Boston, MA: Mid-sized biotech company developing cell and gene therapies
Associate Director, Program Management, Watertown, MA: Small, Clinical-stage biopharma company developing RNA-modulating drugs to treat rare and ultra-rare diseases
Associate Director, Toxicology, Greater Boston, MA: Mid-sized clinical stage biopharma developing novel biologic treatments for rare diseases
Associate Director, Cell Therapy, Cambridge, MA: Mid-sized biotech pioneering cell therapies for intractable diseases
Contract
- Sr Research Associate, Platform Engineering, Cambridge, MA, Small biotech company developing cell and gene therapy for multiple areas
- Computational Biologist, Data Sciences, Cambridge, MA, large biotech company working with cellular metabolism in rare diseases
- Biologist, Hematology, Cambridge, MA, large biotech company working with cellular metabolism in blood disorders
- In Vivo Research Associate, Pharmacology, Cambridge, MA, large biotech company working with cellular metabolism in blood disorders and rare diseases
- Associate Scientist, NGS, Boston, MA, Rapidly growing startup developing unique molecular approach for Gene Therapy
- Sr. Associate Scientist, Boston, MA, Rapidly growing startup using gene therapy for discovery and development.
Success Stories
The people we place in R&D are directly responsible for discovering and developing life changing medicines for patients all over the world. Read about our success placing talent that makes a difference.
Success Stories